Wall Street Associates’s Edwards Lifesciences EW Stock Holding History

Wall Street Associates’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$468K	Sell	15,000 -30	-0.2%	-$972	0.31%	108
2016 Q3	$604K	Hold	15,030	–	–	0.21%	113
2016 Q2	$500K	Hold	15,030	–	–	0.2%	121
2016 Q1	$442K	Hold	15,030	–	–	0.18%	132
2015 Q4	$396K	Hold	15,030	–	–	0.11%	236
2015 Q3	$356K	Buy	+15,030	New	+$363K	0.07%	265

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wall Street Associates's EW Position: Q4 2016 in Review

Wall Street Associates reduced its Edwards Lifesciences (EW) stake by 0.2% in Q4 2016, selling an estimated $972 and leaving 15,000 shares worth $468K. The position accounts for 0.31% of the portfolio, ranked #108.

Wall Street Associates first reported a position in EW in Q3 2015 and has held it in 6 quarters since. The position peaked at $604K in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

Wall Street Associates held 15,000 shares of Edwards Lifesciences worth $468K as of Q4 2016.
Wall Street Associates sold 30 Edwards Lifesciences shares in Q4 2016, an estimated $972.
Edwards Lifesciences made up 0.31% of Wall Street Associates's portfolio in Q4 2016, its #108 holding.
Wall Street Associates first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 6 quarters since.
Wall Street Associates's Edwards Lifesciences position peaked at $604K in Q3 2016.
686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.